当前位置:首页 - 行情中心 - 药康生物(688046) - 财务分析

药康生物

(688046)

  

流通市值:72.32亿  总市值:72.32亿
流通股本:4.10亿   总股本:4.10亿

药康生物(688046)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润0.71亿元,每股收益0.17元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益216791.22万元,未分配利润46122.39万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产279849.04万元,负债63057.82万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入374,808,989.09170,855,596.98686,837,009.6509,718,216.98
营业总成本287,113,871.94135,710,404.13580,186,527.9414,793,749.59
其他经营收益
营业利润77,525,168.7330,673,653.95119,367,805.5799,210,739.46
利润总额77,442,220.6930,673,653.96119,214,997.9499,198,919.01
净利润70,905,477.1429,980,260.4109,819,819.398,214,378.6
每股收益
其他综合收益-555,105.94-98,315.247,553,752.88-198,986.15
综合收益总额70,350,371.229,881,945.16117,373,572.1898,015,392.45
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计1,781,760,715.631,719,421,426.161,709,773,844.341,677,726,535.05
非流动资产:
非流动资产合计1,016,729,686.4931,542,907.09862,871,431.31855,813,951.11
资产总计2,798,490,402.032,650,964,333.252,572,645,275.652,533,540,486.16
流动负债:
流动负债合计543,757,965.56397,976,772.17371,195,620.33341,384,959.63
非流动负债:
非流动负债合计86,820,268.0891,066,227.4466,723,335.7168,841,336.4
负债合计630,578,233.64489,042,999.61437,918,956.04410,226,296.03
所有者权益(或股东权益):
归属于母公司股东权益合计2,167,912,168.392,161,921,333.642,134,726,319.612,123,314,190.14
股东权益合计2,167,912,168.392,161,921,333.642,134,726,319.612,123,314,190.14
负债和股东权益合计2,798,490,402.032,650,964,333.252,572,645,275.652,533,540,486.16
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计317,753,772.45141,686,709.44674,117,821.39420,477,343.76
经营活动现金流出小计302,488,793.84168,414,315.17583,803,561.86436,378,303.47
经营活动产生的现金流量净额15,264,978.61-26,727,605.7390,314,259.53-15,900,959.72
投资活动产生的现金流量:
投资活动现金流入小计919,466,872.79375,409,357.781,918,676,148.341,421,657,306.96
投资活动现金流出小计1,266,130,881.5752,289,074.171,759,783,304.331,368,772,565.08
投资活动产生的现金流量净额-346,664,008.71-376,879,716.39158,892,844.0152,884,741.88
筹资活动产生的现金流量:
筹资活动现金流入小计231,699,600119,450,00097,950,00067,950,000
筹资活动现金流出小计81,276,424.5272,664,988.68206,894,763.94172,900,850.89
筹资活动产生的现金流量净额150,423,175.4846,785,011.32-108,944,763.94-104,950,850.89
汇率变动对现金及现金等价物的影响1,744,503.74532,829.53959,889.98-1,355,366.52
现金及现金等价物净增加额-179,231,350.88-356,289,481.27141,222,229.58-69,322,435.25
期末现金及现金等价物余额521,984,091.85344,935,989.46701,215,442.73490,670,777.9
补充资料:
现金及现金等价物的净增加额-179,231,350.88-141,222,229.58-
最新报告期:2025-09-05
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
野村东方国际证券孔令岩------2025-09-05
开源证券汪晋,余汝意0.320.400.472025-08-27
平安证券叶寅,倪亦道0.310.390.482025-08-25
国信证券马千里0.320.400.462025-08-25
TOP↑